The prognostic values of the peroxiredoxins family in ovarian cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic values of the peroxiredoxins family in ovarian cancer
Authors
Keywords
-
Journal
BIOSCIENCE REPORTS
Volume 38, Issue 5, Pages BSR20180667
Publisher
Portland Press Ltd.
Online
2018-08-13
DOI
10.1042/bsr20180667
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Significance of aquaporins’ expression in the prognosis of gastric cancer
- (2018) Saroj Thapa et al. BIOSCIENCE REPORTS
- Peroxiredoxin 5 overexpression enhances tumorigenicity and correlates with poor prognosis in gastric cancer
- (2017) Bokyung Kim et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The Human Protein Atlas – an important resource for basic and clinical research
- (2016) Cecilia Lindskog Expert Review of Proteomics
- Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases
- (2016) Mi Hee Park et al. PHARMACOLOGY & THERAPEUTICS
- Expression and clinical value of peroxiredoxin-1 in patients with pancreatic cancer
- (2015) C.-Y. Cai et al. EJSO
- PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model
- (2015) Hyung-Mun Yun et al. FREE RADICAL BIOLOGY AND MEDICINE
- Dysregulation of redox-state-regulating enzymes in melanocytic skin tumours and the surrounding microenvironment
- (2015) Hanna-Riikka Hintsala et al. HISTOPATHOLOGY
- High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index
- (2015) Milla Elvi Linnea Kuusisto et al. JOURNAL OF CLINICAL PATHOLOGY
- Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma
- (2015) Fanghua Gong et al. MEDICAL ONCOLOGY
- The phospholipase A2 activity of peroxiredoxin 6 promotes cancer cell death induced by tumor necrosis factor alpha in hepatocellular carcinoma
- (2015) Xiao Xu et al. MOLECULAR CARCINOGENESIS
- Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling
- (2015) Arden Perkins et al. TRENDS IN BIOCHEMICAL SCIENCES
- Expression of cyclooxygenase-2, peroxiredoxin I, peroxiredoxin 6 and nuclear factor-κB in oral squamous cell carcinoma
- (2015) EUN-YOUNG LEE et al. Oncology Letters
- Serum Peroxiredoxin3 is a Useful Biomarker for Early Diagnosis and Assessemnt of Prognosis of Hepatocellular Carcinoma in Chinese Patients
- (2014) Liang Shi et al. Asian Pacific Journal of Cancer Prevention
- PRDX6 promotes lung tumor progression via its GPx and iPLA2 activities
- (2014) Hyung-Mun Yun et al. FREE RADICAL BIOLOGY AND MEDICINE
- Proteomic Analysis of Bladder Cancer Indicates Prx-I as a Key Molecule in BI-TK/GCV Treatment System
- (2014) Li Jiang et al. PLoS One
- Induction of Peroxiredoxin 1 by Hypoxia Regulates Heme Oxygenase-1 via NF-κB in Oral Cancer
- (2014) Min Zhang et al. PLoS One
- Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling
- (2013) Weidong Lu et al. CANCER LETTERS
- Prognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patients
- (2013) Dengbo Ji et al. CARCINOGENESIS
- Comparison of the Five Sonographic Morphology Scoring Systems for the Diagnosis of Malignant Ovarian Tumors
- (2013) S. Klangsin et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma
- (2013) Qi-Kai Sun et al. MEDICAL ONCOLOGY
- siRNA targeting of PRDX3 enhances cisplatin-induced apoptosis in ovarian cancer cells through the suppression of the NF-κB signaling pathway
- (2013) JIE DUAN et al. Molecular Medicine Reports
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- Peroxiredoxin III protein expression is associated with platinum resistance in epithelial ovarian cancer
- (2013) Xin-yan Wang et al. TUMOR BIOLOGY
- Expression of Peroxiredoxin 1, 2, 3, and 6 Genes in Cancer Cells during Drug Resistance Formation
- (2012) E. V. Kalinina et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
- (2012) Paul D. Ray et al. CELLULAR SIGNALLING
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin–binding phosphoprotein 50 in cholangiocarcinoma
- (2012) Ponlapat Yonglitthipagon et al. HUMAN PATHOLOGY
- Antibodies for profiling the human proteome-The Human Protein Atlas as a resource for cancer research
- (2012) Anna Asplund et al. PROTEOMICS
- Expression and prognostic significance of human peroxiredoxin isoforms in endometrial cancer
- (2012) SEULHEE HAN et al. Oncology Letters
- Peroxiredoxin 2 in the nucleus and cytoplasm distinctly regulates androgen receptor activity in prostate cancer cells
- (2011) Masaki Shiota et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy
- (2011) In-Sung Song et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of PRDX4 and P4HA2 as Metastasis-Associated Proteins in Oral Cavity Squamous Cell Carcinoma by Comparative Tissue Proteomics of Microdissected Specimens Using iTRAQ Technology
- (2011) Kai-Ping Chang et al. JOURNAL OF PROTEOME RESEARCH
- Regulation of reactive oxygen species generation in cell signaling
- (2011) Yun Soo Bae et al. MOLECULES AND CELLS
- Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling
- (2011) Q. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancer
- (2011) Caroline M. Woolston et al. RADIOTHERAPY AND ONCOLOGY
- Survival of patients with ovarian cancer in central and northern Denmark, 1998–2009
- (2011) Grann et al. Clinical Epidemiology
- Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors
- (2010) Sally Järvelä et al. BMC CANCER
- Peroxiredoxin 6 Overexpression Attenuates Cisplatin-Induced Apoptosis in Human Ovarian Cancer Cells
- (2010) Jhang Ho Pak et al. CANCER INVESTIGATION
- DNA Adduct 8-Hydroxydeoxyguanosine, a Novel Putative Marker of Prognostic Significance in Ovarian Carcinoma
- (2010) Peeter Karihtala et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Role of Peroxiredoxin I in Rectal Cancer and Related to p53 Status
- (2010) Miao-Fen Chen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
- (2010) MP Coleman et al. LANCET
- Selective Association of Peroxiredoxin 1 with Genomic DNA and COX-2 Upstream Promoter Elements in Estrogen Receptor Negative Breast Cancer Cells
- (2010) Xuemei Wang et al. MOLECULAR BIOLOGY OF THE CELL
- Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4
- (2010) Anamika Basu et al. PROSTATE
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity
- (2009) Juxiang Cao et al. EMBO JOURNAL
- Proteomic Identification of Overexpressed PRDX 1 and Its Clinical Implications in Ovarian Carcinoma
- (2009) Kwang-hoe Chung et al. JOURNAL OF PROTEOME RESEARCH
- Proteomic identification of tumor-associated protein in ovarian serous cystadenocarinoma
- (2008) Xiu-Qin Li et al. CANCER LETTERS
- Up-Regulation of Peroxiredoxin 1 in Lung Cancer and Its Implication as a Prognostic and Therapeutic Target
- (2008) J.-H. Kim et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now